LMT three-lens brief
Evidence-based stock research on LMT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Debt-to-equity of 276% — balance-sheet-heavy.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $615.74 — 19% above current (19 analysts).
- Debt-to-equity of 276% — balance-sheet-heavy.
- Earnings scheduled 2026-07-21.
LMT closed at $515.51 (-0.53%) as of 2026-07-10. Market cap: $118.86B. P/E (trailing) 25.0. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $615.74 — 19% above current (19 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; debt-to-equity of 276% — balance-sheet-heavy.. Last quarter: Revenue $18.02B, net income $1.49B, free cash flow $3.99B. Watching for: 2026-07-21 earnings release (10 days out).
Why three lenses on LMT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine LMTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/LMT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath LMT brief"></iframe>